Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Francisco Porcel-Pastrana
Observed name:
Porcel-Pastrana, Francisco
Institutions:
Instituto Maimónides de Investigación Biomédica de Córdoba,
Hospital Universitario Reina Sofía,
University of Córdoba
Observed institutions:
Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition,
Instituto Maimónides de Investigación Biomédica de Córdoba,
Centro de Investigación Biomédica en Red,
Hospital Universitario Reina Sofía,
University of Córdoba
ORCID:
0000-0002-1664-2556
Observed ORCID:
0000-0002-1664-2556
OpenAlex ID:
A5024595801
SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer
2024
·
Antonio J. Montero-Hidalgo
, Juan M. Jiménez-Vacas
, et al.
·
Science Advances
·
19
Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate cancer: Oncogenic role of PABPN1
2024
·
Prudencio Sáez-Martínez
, Francisco Porcel-Pastrana
, et al.
·
Cancer Letters
·
13
LRP10, PGK1 and RPLP0: Best Reference Genes in Periprostatic Adipose Tissue under Obesity and Prostate Cancer Conditions
2023
·
Jesús M. Pérez-Gómez
, Francisco Porcel-Pastrana
, et al.
·
International Journal of Molecular Sciences
·
13
PDF
Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool
2022
·
Vicente Herrero-Aguayo
, Prudencio Sáez-Martínez
, et al.
·
Molecular Therapy — Nucleic Acids
·
13
Somatostatin, Cortistatin and Their Receptors Exert Antitumor Actions in Androgen-Independent Prostate Cancer Cells: Critical Role of Endogenous Cortistatin
2022
·
Prudencio Sáez-Martínez
, Francisco Porcel-Pastrana
, et al.
·
International Journal of Molecular Sciences
·
10
Cellular and Molecular Evidence of the Synergistic Antitumour Effects of Hydroxytyrosol and Metformin in Prostate Cancer
2025
·
Francisco Porcel-Pastrana
, Antonio J. Montero-Hidalgo
, et al.
·
International Journal of Molecular Sciences
·
7
PDF
miR-191–5p: A tumour suppressor miRNA and a personalized biomarker and potential therapeutic tool connecting prostate cancer and obesity
2025
·
Francisco Porcel-Pastrana
, Antonio J. Montero-Hidalgo
, et al.
·
Biomedicine & Pharmacotherapy
·
6
Periprostatic adipose tissue-derived adipokine profile in prostate cancer patients reveals two distinct molecular phenotypes linked to obesity-related comorbidities: multifaceted role of lipocalin-2
2026
·
Jesús M. Pérez-Gómez
, Antonio Prats-Escribano
, et al.
·
Cell Communication and Signaling
·
5
Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic target
2024
·
Antonio J. Montero-Hidalgo
, Enrique Gómez-Gómez
, et al.
·
Molecular Therapy Oncology
·
3
Strategic Designs to identify the best housekeeping genes for the characterization of biomarkers in adipose tissue of patients with obesity and cancer
2023
·
Gomez Jesus Perez
, Francisco Porcel-Pastrana
, et al.
·
Endocrine Abstracts
·
1
P219 - ECE_2258 - Periprostatic adipose tissue-secreted miR-6798-5p in obesity acts as a oncomiR regulating prostate cancer aggressiveness through the TAGLN2 gene
2026
·
Laura Arroyo-Millán
, Francisco Porcel-Pastrana
, et al.
·
European Journal of Endocrinology
PDF
Genomic characterization of upper urinary tract urothelial carcinoma and clonal evolution of intravesical recurrences
2026
·
J. Alberto Nakauma-Gonzalez
, Veronika Bahlinger
, et al.
·
medRxiv
PDF
Decodificando nuevos mecanismos celulares y moleculares implicados en la fisiopatología del cáncer de próstata y en su relación con la obesidad
2026
·
Porcel-Pastrana, Francisco
·
Universidad de Córdoba Insitutional Repository (Universidad de Córdoba)
Defining the clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and exploitable therapeutic target
2025
·
Antonio Prats-Escribano
, Antonio Jesus Montero-Hidalgo
, et al.
·
Endocrine Abstracts
Dysregulation of a RNA exosome component: a driving force behind prostate cancer progression
2025
·
Francisco Porcel-Pastrana
, Prudencio Saez-Martinez
, et al.
·
Endocrine Abstracts
MiR-191-5p represents a potential personalized diagnostic and therapeutic tool in the pathophysiological interplay between obesity and prostate cancer
2025
·
Laura Arroyo-Millan
, Francisco Porcel-Pastrana
, et al.
·
Endocrine Abstracts
MiR-191-5p represents a potential personalized diagnostic and therapeutic tool for PCa patients, especially in obesity conditions
2023
·
Francisco Porcel-Pastrana
, Vicente Herrero-Aguayo
, et al.
·
Endocrine Abstracts
Exposing the crosstalk between obesity and prostate cancer: miR-191-5p as personalized diagnostic and therapeutic tool
2022
·
Francisco Porcel-Pastrana
, Vicente Herrero-Aguayo
, et al.
·
Endocrine Abstracts
Show more works
View as search
Works count:
18
Citation count:
90
H-index:
6
I10-index:
5
Year
Topic
Type